Baxter concedes FDA plasma collection violations:
This article was originally published in Clinica
Executive Summary
Baxter International is retraining its staff at newly-acquired Sera-Tec Biologicals in Albany, Georgia following a warning letter from the FDA concerning its manufacturing practices. The company concedes that FDA inspectors discovered seven plasma units which tested positive for syphilis had been despatched and that blood donors' test results had been misidentified and that blood had been accepted from donors who had previously been banned from donation.